콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?

요약

Hims & Hers faces profit pressure in first-quarter 2026, though subscribers increase and a Novo Nordisk GLP-1 partnership broadens weight-loss care.